Dalpiciclib Extends Progression-Free Survival in HR+/HER2- Advanced Breast Cancer

Oncologist. 2021 Jun 21. doi: 10.1002/onco.13865. Online ahead of print.NO ABSTRACTPMID:34152061 | DOI:10.1002/onco.13865
Source: The Oncologist - Category: Cancer & Oncology Source Type: research